Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial
Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag updated to v3.5.4, indicating a minor platform update on the page. The update does not alter the study details or other content displayed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s footer revision indicator is updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change without modifying the study content displayed.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision history updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3, replacing the previous version.SummaryDifference0.1%

- Check110 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing v3.4.1, indicating a platform update with no substantive changes to study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.